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Abstract 
We previously reported that /3-adrenergic receptors are increased in cerebral cortex and hippocampus in rats treated 
chronically with morphine and subsequently down-regulated after morphine withdrawal [22,23]. The changes in receptor density 
in hippocampus were accompanied by a corresponding super- and subsensitivity, respectively, in /3-adrenergic responsiveness, as 
assessed electrophysiologically by measuring the ability of isoproterenol to augment population spike responses in the slice. In 
this study, we compared the ability of isoproterenol to reduce the Ca2+-activated K + slow afterhyperpolarization (slow AHP) in 
pyramidal neurons in hippocampal slices from opiate-naive and chronic morphine-treated rats to determine whether such 
changes in /3-adrenergic receptor function are localized postsynaptically. Chronic treatment of rats with morphine produced a 
3.5-fold parallel shift to the left in the concentration-response curve for isoproterenol and reduced the ECs~ from 4.8 _+ 1.3 to 
1.4 _+ 0.5 nM. In contrast, sensitivity and maximal responsiveness to isoproterenol was markedly decreased in pyramidal neurons 
recorded in slices from morphine withdrawn animals. The concentration-response curves for inhibition of the slow AHP by 
carbachol or forskolin were not affected by chronic morphine treatment. However, blockade of the slow AHP by forskolin was 
significantly reduced in pyramidal neurons studied after morphine withdrawal. These data suggest that the increase in 
electrophysiological responsiveness to /3-adrenergic receptor stimulation found in hippocampus after chronic morphine treat- 
ment most likely resulted from an up-regulation in postsynaptic membrane receptors, whereas alterations occurring beyond the 
receptor level may be involved in the desensitization that is associated with morphine withdrawal. 
Key words: Chronic morphine; Morphine withdrawal;/3-Adrenoceptor; Ca2+-activated potassium afterhyperpolarization; Pyrami- 
dal neuron; Hippocampal slice 
1. Introduct ion 
Much evidence suggests that the central noradrener- 
gic system arising from neurons of the pontine nucleus 
locus coeruleus (LC) may play an important role in 
opiate dependence and withdrawal (for review, see 
[31]). For example, naloxone-precipitated withdrawal 
of opiate-dependent rats dramatically increases the 
spontaneous firing rate of LC neurons [2,29,37], and 
the time course of increased LC activity closely matches 
that of several withdrawal behaviors [29]. In addition, 
administration of the a2-adrenergic agonist clonidine 
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suppresses the withdrawal-induced hyperactivity in LC 
neurons [2] and blocks several components of the mor- 
phine-withdrawal syndrome in opiate-dependent rats, 
monkeys and man [13,30]. 
Other data indicate that compensatory adaptations 
in postsynaptic receptors on LC target neurons occur 
after long-term opiate administration, and these may 
contribute as well to the elevation in central noradren- 
ergic activity that underlies withdrawal phenomena. 
Work from this and other laboratories has shown that 
chronic treatment of rats with morphine increases the 
number of /3-adrenergic receptors in cerebral cortex 
and hippocampus, without changing the affinity of these 
receptors for agonists or antagonist ligands [16,22,23]. 
The up-regulation in /3-adrenergic receptors found af- 
ter chronic morphine treatment appeared to be of 
functional significance, since it was accompanied by an 
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increased electrophysiological responsiveness to /3- 
adrenergic agonists as evidenced by an enhanced abil- 
ity of isoproterenol to augment CA1 population spike 
responses evoked by Schaffer collateral stimulation in 
rat hippocampal  slices [22]. Conversely, withdrawal of 
morphine-dependent  rats was associated with a de- 
crease in the number  of hippocampal /3-adrenergic 
receptors and a corresponding reduction in electro- 
physiological sensitivity and maximal responsiveness to 
isoproterenol [22]. The latter changes could represent a 
compensatory down-regulation in the /3-adrenergic re- 
ceptor system in response to the exaggerated synaptic 
release of norepinephrine that occurs during with- 
drawal [7,9,29]. Moreover,  the emergence of such sub- 
sensitivity in postsynaptic /3-adrenergic receptors, if 
shown to be of a persistent nature, may provide the 
cellular basis for the hypofunction in central noradren- 
ergic and peripheral  sympathetic systems that charac- 
terizes the secondary or protracted abstinence syn- 
drome [21]. 
The population spike response to Schaffer collateral 
stimulation that is recorded extracellularly from the 
CA1 cell layer represents the summated firing of large 
numbers of pyramidal neurons [4]. Measurements  that 
are derived from monitoring population spike ampli- 
tude are sensitive to both presynaptic and postsynaptic 
influences that affect the probability of pyramidal neu- 
ron discharge to this excitatory input. The increases in 
population spike amplitude produced by the applica- 
tion of /3-adrenergic  agonists are known to occur inde- 
pendent  of changes in the level of synaptic activation 
(as reflected by the constancy of the dendritic field 
EPSP) [22,24]. On the other hand, activation of postsy- 
napt ic /3-adrenergic  receptors can directly increase the 
responsiveness of pyramidal neurons to depolarizing 
stimuli by producing blockade of the Ca2+-activated 
K + current, 1An e [14,18]. This conductance underlies 
the slow A H P  that follows a burst of action potentials 
in pyramidal neurons and by this latter action serves 
normally to limit stimulation-induced repetitive firing 
[14,18,32]. In addition, application of /3-adrenergic 
agents or norepinephrine to the slice has been shown 
to modify local inhibitory GABAergic  input to pyrami- 
dal neurons and thereby could act indirectly to influ- 
ence their excitability and probability of spike dis- 
charge [5,10]. Consequently, it remains unclear to what 
extent the alterations in ability of /3-adrenergic ago- 
nists to augment population spike responses that ac- 
company morphine dependence and withdrawal might 
reflect changes in 'presynaptic '  receptor populations, 
rather than those localized on pyramidal neurons. 
In the present  study, intracellular recordings were 
obtained from pyramidal neurons in vitro in rat hip- 
pocampal  slices to determine whether the changes in 
hippocampal  sensitivity and responsiveness to/3-adren-  
ergic stimulation found after chronic morphine treat- 
ment primarily reflect alterations loca[ized to postsy- 
naptic receptors on pyramidal neurons. Changes in 
postsynaptic /3-adrenergic receptor function were as- 
sessed by comparing the ability of isoproterenol to 
inhibit the slow A H P  that follows a current-evoked 
burst of action potentials in neurons from opiate-naive 
controls and morphine-dependent  rats before and after 
withdrawal. Similar comparisons were made of the 
abilities of forskolin and carbachol to reduce the slow 
A H P  to ascertain whether any observed changes in 
/3-adrenergic sensitivity or responsiveness after chronic 
opiate t reatment  or withdrawal might involve alter- 
ations occurring beyond the receptor level. /3-Adren- 
ergic blockade of the slow AHP occurs via the G~- 
mediated stimulation of adenylate cyclase and the re- 
sultant increase in intracellular levels of cAMP [19,32]. 
On the other hand, the stimulation of muscarinic re- 
ceptors by carbachol leads to an increased turnover in 
membrane  phosphoinositides and blockade of 1An e 
(and concomitant slow AHP responses) in hippocampal 
pyramidal neurons via a protein kinase C-dependent  
signaling cascade [1,20]. Comparing the effects of 
chronic morphine t reatment  on the responses to iso- 
proterenol and carbachol thus provided us with a means 
to (1) assess the specificity of long-term opiate interac- 
tions with the/3-adrenergic receptor coupled adenylate 
cyclase system and (2) determine whether chronic opi- 
ate t reatment  might alter slow AHP responses by di- 
rectly affecting the underlying conductance IAH e. Some 
of these results have been presented previously in 
preliminary form [1]. 
2. Materials and Methods 
Male, Sprague-Dawley rats (Charles River) weighing 250-350 g 
were used in this study. Rats were treated chronically with morphine 
pellets (containing 75 mg morphine base), implanted subcutaneously 
on the back flank under halothane anesthesia (4% in air). The 
treatment schedule was as follows: rats were implanted with one 
pellet on day one, three pellets on day 3, five pellets on day 5, and 
seven pellets on day 7. This treatment schedule has been shown 
previously to produce a high level of tolerance and dependence on 
morphine [6]. The accelerated morphine regimen was well-tolerated 
by all of the treated animals with rats showing no obvious behavioral 
impairments and maintaining body weight throughout the treatment 
period. 
Brain slices were prepared either two or four days after the last 
implantation of morphine pellets, corresponding to days 9 and 11 of 
the schedule, respectively. In rats rendered dependent by pellet 
implantation, 1 mg/kg of naloxone, injected s.c., precipitated highly 
characteristic 'dominant' withdrawal signs when administered within 
60 h after the final implants. These included hyperactivity, uncontrol- 
lable jumping and increased escape attempts, abnormal swallowing 
movements, diarrhea, teeth chattering and screeching on touch. 
Neurons that were studied in slices prepared on day 9 thus com- 
prised the morphine-dependent group. Those tested 4 days after the 
last pellet implantation were designated opiate-withdrawn, based on 
the occurrence of a spontaneous withdrawal syndrome in the treated 
animals on day 10 of the schedule. The extent and duration of the 
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withdrawal period were determined by monitoring weight loss in the 
animals after cessation of opiate t reatment ,  considered a reliable 
index of morphine  withdrawal in rats [40]. Reduct ions in weight were 
first noted on day 10 of the schedule and peaked by day 11, with the 
average loss exceeding 13% (10 to 18% range, n = 15) of  mean  body 
weight measured  over the course of morphine treatment .  The with- 
drawn animals exhibited other  signs of an abstinence syndrome such 
as abnormal posturing, lacrimation, seminal emissions and screech- 
ing on touch; however, the 'dominant '  signs of precipitated absti- 
nence were typically absent when administration of naloxone was 
delayed until after the onset  of weight loss occurred. 
On the test day, animals were rendered unconscious with CO 2 
and sacrificed by decapitation. The brain was removed and immedi- 
ately placed in ice-cold artificial cerebrospinal fluid (ACSF), contain- 
ing, in mM: NaCI 124, KCI 3.5, MgSO 4 1.5, N a H 2 P O  4 1.0, NaHCO 3 
26.2, glucose 11.0, CaCI 2 2.5, pregassed with 95% 0 2 and 5% CO 2. 
The hippocampus was dissected free, and transverse slices were cut 
at 500 microns on a McIlwain chopper  with the regio inferior and 
dentate  gyrus placed upward. One  slice was transferred immediately 
to the recording chamber  and held submerged between two layers of 
nylon mesh under  continuously flowing ACSF (perfused at 1 m l / m i n )  
pre-warmed to 32.5°C. The remaining slices were placed in an 
incubation chamber  and maintained in oxygenated ACSF at room 
temperature.  Slices were allowed to equilibrate for at least 1 h 
before intracellular recordings were attempted.  During recordings, 
drugs were applied to the slice by switching the bath superfusate  
from normal ACSF to medium containing known concentrat ions of 
drugs. 
Conventional intracellular voltage recordings were obtained from 
CA1 pyramidal neurons using glass microelectrodes filled with 2 M 
KCI (pH = 7.0) and having resistances of 70-120 MS2. Neurons  were 
st imulated to fire action potentials by passage of a short depolarizing 
current pulse through the recording electrode using a s tandard 
bridgebalanced amplifier. Recordings were made in the presence of 
the sodium channel  blocker tetrodotoxin (TTX, 1 ~ M )  and the 
vol tage-dependent  potassium channel  blocker te t rae thylammonium 
(TEA, 5 raM) to enhance  the slow A H P  responses that followed a 
current-evoked burst of spikes. TTX was also used to block axonal 
conduction, thereby eliminating possible confounding effects arising 
from drug actions at sites distal to the pyramidal neuron being 
recorded. Recordings of membrane  voltage were amplified and dis- 
played on an oscilloscope and chart  recorder. The signals were also 
led to a computer  interface which digitized the analog waveforms for 
analysis by a microcomputer  based program (pClamp, Axon Instru- 
ments). 
To quantify the inhibitory action of drugs on the slow AHP, 
samples of four digitized waveforms taken prior to and during drug 
application were averaged. The area of the slow A H P  was calculated 
by integrating with respect to time the hyperpolarizing potential 
falling below baseline. The lower and upper  time limits utilized for 
the integration of the slow AHP  were the time following the current  
pulse when the slow hyperpolarizing potential first emerged from the 
decay phase of the preceding medium AHP  and the time when the 
potential returned to the pre-pulse level, respectively. The area of 
the slow AHP during drug administration was expressed as a per- 
centage of the response measured  in the absence of drug for each 
neuron. 
Data statistical analysis. The results obtained from morphine-  
treated rats were compared to those from opiate-naive controls using 
a two-way analysis of variance (ANOVA)  with repeated measures  on 
one variable (concentration). Post-hoc analysis was done using the 
D u n n e n  test to compare the t reatment  group means  to the control 
group means  at each drug concentration. The concentration of drug 
required to inhibit the control A H P  by 50% (ECs0) was calculated 
using linear regression analysis for cells in which a complete concen- 
t ra t ion-response  curve was obtained. The percent  reduction in the 
response produced at each concentration of drug was expressed by 
normalizing each value to the maximal inhibition obtained in a given 
neuron and multiplying by 100. All data are presented in the text as 
mean  ± S.E.M.. 
Drugs. Carbachol, ( - ) - i sopro te renol ,  te t rae thylammonium chlo- 
ride and tetrodotoxin were purchased from Sigma Chemical Co. and 
forskolin was purchased from Calbiochem. Morphine pellets were 
obtained from the National Institute on Drug Abuse.  
3. Results 
3.1. Effects of chronic morphine treatment on resting 
and actil'e membrane properties 
The resting membrane properties of pyramidal neu- 
rons recorded in slices from chronic morphine-treated 
(n = 23, 12 animals) and morphine-withdrawn rats (n 
= 17, 12 animals) were not significantly different from 
those of control neurons (n = 25, 16 animals) (Table 1). 
In most control and opiate-treated neurons, passage of 
a 150 ms depolarizing pulse (0.5-2.0 nA, intensity) 
through the recording electrode evoked a series of one 
to three Ca 2+ action potentials followed by a medium 
and subsequent slow AHP. The slow AHP was not 
sensitive to the presence of TEA (5 raM) in the bath, 
but was eliminated during perfusion of the Ca 2+ chan- 
nel blocker Cd 2+ (200 /~M) (6 /6  neurons). Intracellu- 
lar administration of the K + channel blocker Cs + also 
completely abolished the slow AHP (3 /3  neurons 
recorded with microelectrodes containing 3M cesium 
acetate). The late slow hyperpolarizing potentials 
recorded in opiate-naive neurons were typically 7-11 
mV in amplitude, 3 -6  s in duration and were accompa- 
nied by a marked decrease in membrane input resis- 
tance. The properties of the slow AHP recorded in 
morphine-treated neurons were essentially indistin- 
guishable from those of responses elicited in controls 
(Table 1). The mean durations of the slow AHP deter- 
mined for all neurons within the control, chronic mor- 
phine-treated and withdrawn groups were 4098 _+ 297, 
3612 _+ 295 and 3712 _+ 196 ms, respectively. In addi- 
tion, determination of the time constants of decay from 
a representative sampling of neurons yielded values of 
1.9 _+ 0.3 ms for controls (n = 9), 1.8 ± 0.5 ms for the 
chronic treated group (n = 6) and 2.0 _+ 0.4 ms for the 
withdrawn group (n = 4). 
Table l 
Comparison of resting membrane  properties and Ca2*-activated 
potassium slow AHPs  in CA1 pyramidal neurons from control and 
chronic morphine- t reated rats 
RMP (mV) AHP AHP AHP 
Amplit. Durat ion Decay r 
(mV) (s) (s) 
Controls (25) - 7 0 . 1 + 1 . 4  -6.1+_0.3 4 .1+0.3 1.9-+0.3 
Treated (23) - 66.8 -+ 1.2 - 5.3 + (].4 3.6 + {/.3 1.8 -+ 0.2 
Withdrawn (17) -67.8_+2.1 - 5 . 2 + 0 . 4  3.7_+0.2 2.0+_0.3 
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Control ~ Wash 
. . . . . .  
2s 
B. Chronic Morphine 
~ 0 . 3  nM 
. . . . . .  
~- "~30  nM 
~10 nM 
Fig. 1. A - C :  representative records from three experiments  compar- 
ing sensitivity to isoproterenol-induced blockade of the Ca e+- 
activated K + slow AHP  in pyramidal neurons  from an opiate-naive 
(A), chronic morphine- t reated (B) and morphine-withdrawn rat (C). 
Sensitivity to the inhibitory effect of isoproterenol was increased 
after chronic morphine  treatment ,  but it was decreased and the 
maximal effect of  the agonist reduced in the withdrawn neuron,  
compared to the opiate naive-control. Each trace is the computer-  
ized average of slow A H P  responses elicited by 4 stimulation trials. 
Rest ing membrane  potentials were - 70 mV, - 69 mV and - 68 mV 
for the neurons depicted in A, B and C, respectively. 
C. Withdrawal 
In these experiments, slices that were prepared from 
chronic morphine-treated rats were maintained contin- 
uously in ACSF that did not contain morphine. No 
evidence of a withdrawal response (e.g. membrane 
depolarization or increased postsynaptic potential ac- 
tivity) was observed in any of the dependent  neurons 
during intracellular recording over an 8 h period from 
the time of slice preparation. In previous studies, per- 
fusion of opiate-free medium for up to 8 h or challenge 
with naloxone also failed to elicit any electrophysiologi- 
cal signs of withdrawal in hippocampal or LC neurons 
in slice preparations from chronic morphine-treated 
rats [6,42]. 
3.2. ~-Adrenergic sensitiui~ and responsiueness after 
chronic morphine treatment 
Bath application of isoproterenol reversibly reduced 
the slow AHP that followed a current-evoked burst of 
action potentials in all CA1 pyramidal neurons exam- 
ined. The left voltage trace in Fig 1A. illustrates a 
typical slow AHP response of a control neuron elicited 
by passage of a 150 ms depolarizing current pulse (1.0 
nA) through the recording electrode. This neuron fired 
a single broad Ca 2÷ action potential (not shown in this 
truncated record) followed by a large hyperpolarization 
of 11.5 mV amplitude and 4.3 s duration. Addition of 
10 or 30 nM isoproterenol to the bath resulted in st 
large reduction in the area of the slow AHP (middle 
panel) which gradually reversed upon washout of the 
drug (right panel). The inhibition of the slow AHP by 
isoproterenol was concentration-dependent and typi- 
cally occurred independent of changes in the resting 
membrane potential. Depolarizations of a few mV 
accompanied blockade of these afterhyperpolarizations 
in only 6 neurons (3 control and 3 dependent).  How- 
ever, in roughly 25% of control (6 /25)  and chronic 
morphine-treated neurons (7/23)  administration of the 
fl-adrenergic agonist had a biphasic effect on these 
responses, with an increase in slow AHP amplitude 
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Fig. 2. A: concent ra t ion- response  curves for inhibition of the slow AHP by isoproterenol in pyramidal neurons from control (open circlesL 
chronic morphine- t reated (filled circles) and morphine-withdrawn rats (filled triangles). Chronic morphine t reatment  shifted the concent ra t ion-  
response curve 3.5-fold to the left and reduced the ECs0 for isoproterenol from 4.8 + 1.3 nM to 1.4_+ 0.5 nM. In contrast, the ECs0 for 
isoproterenol was increased to 71.1 _+ 29.6 nM and the maximal effect of the agonist was reduced in neurons studied after morphine withdrawal. 
B: comparison of isoproterenol concent ra t ion-response  curves from opiate-naive controls (open circles) and morphine-withdrawn neurons (filled 
squares) studied 7 days following the last pellet implantation. Symbols represent  the mean  values and error bars the s.e.m of determinations in 
6 -8  neurons.  * P < 0.05, ** P < 0.01, compared to control. 
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Table 2 
Comparison of ECs( I values for inhibition of the slow AHP by 
isoproterenol, forskolin and carbachol before and after chronic mor- 
phine treatment 
Isoproterenol (nM) Forskolin (p~M) Carbachol(~M) 
Controls 4.5_+ 1.2(5) 1.7_+0.4(10) 1.3_+0.3(7) 
Treated 1.4+ 0.5(6) 1.2+0.2 (5) 1.9_+0.6(7) 
Withdrawn 71.1_+29.6(7)* 6.6+_2.1 (6)* 2.1_+0.6(4) 
Values represent the means + S.E.M. for the number of experiments 
shown in parentheses. 
* Significantly different from control at P < 0.05 by Mann-Whitney 
U-test. 
drug at higher concentrations (above 100 nM, see be- 
low). 
Sensitivity of pyramidal neurons to the inhibitory 
effect of isoproterenol on the slow AHP was increased 
after chronic morphine t reatment  (Table 2). It can be 
seen from the voltage traces depicted in Fig. 1 that 1 
nM isoproterenol had a more potent  inhibitory effect 
in the neuron from the chronic morphine-treated ani- 
mal (Fig. 1B), producing 80% inhibition of the slow 
AHP,  compared to 26% inhibition of the response in 
the control neuron (Fig. 1A). In addition, the maximal 
effect was obtained at a lower concentration of isopro- 
terenol in the treated neuron (97% inhibition of the 
AHP at 10 nM), whereas 3- to 10-fold higher concen- 
trations of the agonist were required to achieve compa- 
rable effects (86% and 89% inhibition of the response, 
respectively) in the opiate-naive cell. Fig. 2A compares  
the concent ra t ion-response  curves for inhibition of the 
slow AHP by isoproterenol in control (n = 8) mor- 
phine-treated (n = 8) and morphine-withdrawn groups 
of neurons (n = 6), Chronic t reatment  of rats with 
morphine resulted in a 3.5-fold parallel shift to the left 
in the concent ra t ion-response  curve for isoproterenol 
(Fig. 2A) with a significant group effect (F1~22 = 18.106, 
P < 0.0003, repeated measures ANOVA).  The mean 
inhibitory effect produced was significantly greater  in 
the morphine-dependent  neurons compared to con- 
trols at all concentrations of the agonist, except for 100 
nM which yielded maximal effects in both groups. 
However, the ECs0 for inhibition by isoproterenol was 
reduced only slightly after chronic morphine t reatment  
from 4.8 + 1.3 nM to 1.4 _+ (I.5 nM (P  < 0.10). 
It was not always possible to examine the complete 
concentra t ion-response  relationship for isoproterenol 
in each neuron because of the occurrence of biphasic 
effects. Administration of isoproterenol in a 3-fold 
incremental series of concentrations from 0.3 to 30 nM 
typically resulted in graded reductions in slow AHP 
amplitude and area that varied directly with agonist 
concentration. However, when measure-ments  were 
made in the presence of higher concentrations of ago- 
nist, the number  of Ca 2 + action potentials evoked by a 
depolarizing current pulse of constant amplitude and 
duration increased (compared to the pre-drug condi- 
tion) in some control (n = 6) and morphine-dependent  
neurons (n = 7), and there was a corresponding en- 
hancement  in the amplitude and duration of the slow 
AHP. For this reason, it was not possible to obtain a 
reliable measure of the agonist-induced inhibition of 
the slow AHP with 300 nM isoproterenol in neurons 
from the morphine-dependent  group. It seemed likely 
that such biphasic effects were related to a desensitiza- 
tion of /3-adrenergic receptors, since facilitation of 
Ca 2+ spike generation and slow AHP responses was 
not encountered when 300 nM isoproterenol was ini- 
tially tested in neurons without prior exposure to lower 
concentrations of the agonist. 
In contrast to the results obtained after chronic 
morphine treatment,  neurons (n = 6) studied in slices 
from morphine-withdrawn rats showed a significant 
decrease in postsynaptic sensitivity and responsiveness 
to/3-adrenergic  stimulation (Table 2, Figs. 1C and 2A). 
The concentra t ion-response  curve for slow AHP inhi- 
bition by isoproterenol was shifted 20-fold to the right 
(measured at ECs~ ~ level) and downward in withdrawn 
neurons, compared to opiate naive controls (Fl,_U = 
33.29, P < 0.0001) (Fig. 2A). The ECs,  for isopro- 
terenol was increased significantly in morphine-  
withdrawn neurons (71.1 _+ 29.6 nM, P < 0.01, com- 
pared to 4.8 +_ 1.3 nM for controls), and the maximal 
responsiveness at 300 nM isoproterenol was reduced by 
60% ( P < 0 . 0 1 ) .  As shown in Fig. 1, for example, 10 
nM isoproterenol inhibited the slow AHP by 75% in an 
opiate-naive neuron, whereas 30 and 100 nM isopro- 
terenol produced only a 30 and 56% inhibition of the 
response, respectively, in a neuron recorded in a slice 
from a morphine-withdrawn rat. Moreover, in the lat- 
ter neuron 300 nM isoproterenol failed to produce 
complete blockade of the slow AHP. 
To determine the extent and time course of recovery 
from the /3-adrenergic subsensitivity found in neurons 
from morphine-withdrawn rats, we examined the abil- 
ity of isoproterenol to reduce the slow AHP in neurons 
(n = 8) 1 week after the last implantation of morphine 
pellets. At this time (day 14 of the schedule), 4 days 
had elapsed since the expression of withdrawal signs in 
these animals. Fig. 2B compares the concentra t ion-re-  
sponse curves for inhibition of the slow AHP by isopro- 
terenol in control neurons and neurons from chronic 
morphine-treated rats studied on day 14, after recovery 
from withdrawal. In the latter neurons, the EC~, for 
isoproterenol (ECs,  6.4 ± 2.2 nM) and maximal in- 
hibitory effect produced by the /3-adrenergic agonist 
(82.5 _+ 6.8% at 300 nM) were not significantly differ- 
ent from values in opiate naive controls (ECs~ ~ 4.8 _+ 1.3 
nM and 81.5 +_ 7.2%, P > 0.5). Nor were any significant 
group differences found at any agonist concentration 
tested, compared to controls. 
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3.3. Assessments q[: changes occurring beyond the recep- 
tor lerel 
We next sought to determine whether the alter- 
ations in postsynaptic responsiveness to isoproterenol 
found here could be attributed simply to the up- and 
down-regulation in hippocampal/3-adrenergic receptor 
density, respectively, that occurs after chronic mor- 
phine treatment and withdrawal [22]. To test this possi- 
bility, we compared the ability of forskolin to reduce 
the slow AHP in neurons from opiate-naive controls 
and chronic morphine-treated rats before and after 
withdrawal. Forskotin is known to directly activate the 
catalytic subunit of adenylate cyclase and thereby acts 
beyond the level of the fl-adrenergic receptor to re- 
duce the slow AHP in hippocampal pyramidal neurons 
[19,32]. Thus, we reasoned that if changes in the num- 
ber of postsynaptic /3-adrenergic receptors were solely 
responsible for the alterations in response to isopro- 
terenol, then the inhibitory effect of forskolin was 
likely to be unchanged in neurons taken from chronic 
morphine-treated rats. Bath application of forskolin 
(0.3-30 /~M) produced a concentrat ion-dependent re- 
duction in the area of the slow AHP, which reversed 
within 10-25 min after washout of the drug. This effect 
appeared to be due to a stimulation of cyclase activity, 
since administration of higher concentrations of 1,9-di- 
deoxyforskolin (50-100 /zM), which has non-specific 
effects like the parent compound but does not activate 
adenylate cyclase, was without effect ( 4 /4  neurons, 
data not shown). Chronic treatment of rats with mor- 
phine did not alter the ability of forskolin to reduce the 
slow AHP (Figs. 3 and 4). The ECs0 for forskolin was 
1.2 + 0.2 /zM in neurons from morphine-dependent  
animals (n = 7), which was not significantly different 
from that for controls (1.7 + 0.4 ~M, n = 6). Nor were 
any significant differences detected between the mean 
inhibitory effects produced in the morphine-dependent  
neurons compared to controls over the 100-fold range 
of concentrations (0.3 to 30/.tM) of forskolin that were 
tested. In contrast, in neurons studied after morphine 
withdrawal (n = 6), the ability of forskolin to reduce 
the slow AHP was significantly reduced (Table 2, Figs. 
3 and 4). The concentrat ion-response curve for 
forskolin was shifted 4-fold to the right in withdrawn 
neurons, compared to control (Fig. 4, EL20 = 10.998, 
P <  0.003). Although the EC.s0 for forskolin was in- 
creased in withdrawn neurons (6.6 _+ 2.1 /zM vs. 1.7 _+ 
0.4 ~,M for controls, P < 0.01), the maximal inhibitory 
effect measured at 30 /zM forskolin was similar be- 
tween the two groups. 
In a final series of experiments, we compared the 
inhibitory effects of muscarinic receptor activation on 
the slow AHP in control and chronic morphine-treated 
neurons. The aim of these experiments was to deter- 
mine whether the alterations in /3-adrenergic receptor 
A. Forskolin 
Opiate Naive Chronic Morphine Withdrawal 
"control ~ %  1 /JM ~, - ,u 
"cOnt ro l  con t ro l  
B. Carbachol 2~ 5,,v 
"-~..~ " ~ - 0 . 3  ,uM "~ ,  ~ -  0 . 3  ,uM .... , , ' ~  0 . 3  p M  
~ ' c o n t r o l  " c o n t r o l  c o n t r o l  
Fig. 3. A: representative records from 3 experiments comparing the 
ability of forskolin in varying concentrations to inhibit the slow AHP 
in neurons from an opiate-naive (traces at left), chronic morphine- 
treated (middle traces) and morphine-withdrawn rat (traces at right). 
Sensitivity to forskolin was similar in the chronic morphine-treated 
and control neuron, but was reduced in the withdrawn neuron 
(comparisons made at 1 and 10 /zM) without change in maximal 
effect (measured at 30 ~M). B: records from a similar series of 3 
experiments in which blockade of the slow AHP by varying concen- 
trations of carbachol was compared between control (traces a t  left) 
and chronic morphine-treated neurons studied before (middle traces) 
and after withdrawal (traces at right). Quantitative analyses of  the 
effects produced over a 30-fold range of agonist concentrations (0.3 
to 10 /zM) showed that inhibition of the slow AHP by muscarinic 
receptor activation was unaffected after chronic morphine treatment 
or withdrawal. Traces shown are computerized averages of 4 stimu- 
lus trials, Resting membrane potentials ranged from --68 mV to 
- 7 1  mV for the neurons depicted. 
function induced by chronic morphine treatment were 
confined to the /3-adrenergic receptor-coupled adeny- 
late cyclase system or might be generalized to other 
intracellular signaling cascades that are negatively cou- 
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Forskolin (Log Molar Concentration) 
Fig. 4. Concentrat ion-response curves for forskolin-induced inhibi- 
tion of the slow AHP in neurons from control (open circles), chronic 
morphine-treated (filled circles) and withdrawn rats (filled triangles). 
Sensitivity to forskolin was unchanged after chronic morphine treat- 
ment, but the concentrat ion-response curve was shifted 4-fotd to the 
right and the ECs0 increased from 1.75:0.4 /~M to 6.65:2.1 /zM 
(P  < 0.05) in neurons from morphine withdrawn rats. Symbols repre- 
sent the mean values and error bars the S.E.M. of determinations in 
6-7  neurons. * P < 0.05. 
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Fig. 5. Comparison of concent ra t ion- response  curves for carbachol- 
induced inhibition of the slow AHP  in neurons  from opiate-naive 
(open circles), chronic morphine- t reated (filled circles) and mor- 
phine-withdrawn rats (filled triangles). Blockade of the AHP that 
resulted from the activation of muscarinic receptors was unaffected 
by chronic t rea tment  of rats with morphine  or morphine  withdrawal. 
Symbols represent  mean  values and error bars the S.E.M. of deter- 
mination in 58 neurons.  
pied to IAH P. We first sought to establish that mus- 
carinic and /3-adrenergic receptors modulate the same 
slow Ca2+-activated K + conductance by determining 
whether the inhibitory effects of carbachol and isopro- 
terenol on the slow AHP were non-additive. In all 6 
neurons examined (3 controls and 3 chronic morphine- 
treated), there was occlusion of the inhibitory response 
produced by carbachol (3 /xM) or isoproterenol (30 
nM) when one of the drugs was applied in the presence 
of a near saturating concentration of the other (data 
not shown). This result is consistent with other data in 
the literature which indicate that muscarinic and /3- 
adrenergic receptors are negatively coupled to IAHP in 
rat hippocampal pyramidal neurons [11,14,18,20]. 
Neither chronic morphine treatment nor withdrawal 
altered the ability of carbachol to reduce the slow AHP 
in CA1 pyramidal neurons (Figs. 3 and 5). The ECs0s 
for AHP inhibition by carbachol in neurons from 
chronic morphine-treated (n = 8) or withdrawn rats 
(n = 5) were similar to the value obtained in opiate- 
naive controls (n = 8) (Table 2). The voltage traces in 
Fig. 3B directly compare the reductions in the slow 
AHP produced by 0.3, 1 and 10 /xM carbachol in 
control (left panel), chronic morphine-treated (middle 
panel) and morphine-withdrawn neurons (right panel). 
4. Discussion 
The present results demonstrate that alterations oc- 
cur in postsynaptic /3-adrenergic receptor function in 
hippocampal pyramidal neurons after chronic mor- 
phine administration and withdrawal. The emergence 
of postsynaptic /3-adrenergic receptor supersensitivity 
after chronic morphine treatment was evidenced by a 
3.5-fold leftward shift in the concentrat ion-response 
curve for inhibition of the Ca 2+ activated K + slow AHP 
by isoproterenol. In contrast, neurons in slices pre- 
pared from morphine-withdrawn rats showed a marked 
subsensitivity to isoproterenol and a decrease in maxi- 
mal response to the agonist. The latter changes in 
neuronal responsiveness to /3-adrenergic receptor acti- 
vation showed full recovery back to control levels within 
one week following the expression of withdrawal signs. 
It is well-established that the primary response mea- 
surement employed here, i.e., blockade of the slow 
AHP by isoproterenol, results from activation of /3- 
adrenergic receptors on pyramidal neurons and an 
elevation in intracellular levels of cAMP [14,18,19,32]. 
Moreover, all recordings were made in the presence of 
TTX (1 /xM), ensuring postsynaptic isolation of the cell 
under study. Thus, it is reasonable to conclude that the 
functional alterations in /3-adrenergic receptor re- 
sponse observed were localized postsynaptically to 
pyramidal neurons. The data further suggest that the 
up- and downregulation in /3-adrenergic receptor den- 
sity described previously in rat hippocampus after 
chronic morphine treatment and withdrawal, respec- 
tively [22], involves populations of receptors on pyrami- 
dal neurons. 
The increase in neuronal sensitivity to isoproterenol 
found after chronic morphine treatment is in keeping 
with the results of earlier biochemical studies which 
have demonstrated an enhanced responsiveness of 
adenylate cyclase to /3-adrenergic stimulation in sev- 
eral brain areas in morphine-dependent  rats. Thus, 
chronic administration of morphine in vivo has been 
reported to increase cAMP accumulation by isopre- 
naline and norepinephrine in rat cortical slices [16] and 
to enhance isoproterenol-stimulated adenylate cyc[ase 
activity in monkey cerebella [25]. Prolonged exposure 
to morphine also increased isoprenaline-stimulated 
cAMP production in cultures of rat striatal neurons 
[38]. The latter findings are of particular interest since 
these cultured neurons, unlike other cellular systems 
routinely employed in opiate studies, predominantly 
contain/x-opioid receptors [39], the target of morphine 
action. Our findings that neuronal sensitivity and re- 
sponsiveness to isoproterenol were reduced in slices 
from withdrawn rats are consistent with results of 
Nathanson and Redmond [25] who found that with- 
drawal of morphine-dependent  monkeys is associated 
with decreased isoproterenol-stimulated adenylate cy- 
clase activity. In contrast, Kuriyama found a significant 
increase in cortical cAMP formation by norepinephrine 
after naloxone-precipitated withdrawal of morphine- 
dependent  rats [15]. The explanation for the discrep- 
ancy in results between studies is unclear, but may 
reflect fundamental differences in /3-adrenergic recep- 
tor dynamics (and brain NE turnover) that occur in 
response to acute withdrawal precipitated by naloxone 
vs. that associated with drug abstinence. 
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The magnitude of the increase in postsynaptic sensi- 
tivity to isoproterenol found after chronic morphine 
treatment is close to the effect predicted (see {12]) for 
the 20% elevation in hippocampal /3-adrenergic recep- 
tor density measured in our earlier binding studies [22]. 
The fact that the concentrat ion-response curves for 
inhibition of the slow AHP by forskolin or carbachol 
were unaffected by chronic morphine treatment adds 
credence to the likelihood that changes in the number 
of membrane receptors primarily accounted for the 
increase in neuronal sensitivity to /3-adrenergic stimu- 
lation in slices from morphine-dependent  rats. In pre- 
vious competition binding experiments, we failed to 
detect any significant changes either in the high affinity 
binding of isoproterenol or its inhibitory potency for 
displacement of [3H]dihydroalprenolol in hippoeampal 
membranes prepared from chronic morphine-treated 
or morphine-withdrawn rats, compared to naive con- 
trois [22]. Further, it should be mentioned that the 
major components of the adenylate cyclase cascade 
that mediate /3-adrenergic signal transduetion, includ- 
ing the stimulatory G protein G~ and the activities of 
adenylate cyclase and cAMP-dependent  protein ki- 
nase, are reported to be unchanged in rat hippocampus 
after chronic morphine treatment [35]. We conclude 
from these data that a modest supersensitivity to /3- 
adrenergic receptor stimulation is expressed in hip- 
pocampal CA1 pyramidal neurons after prolonged ex- 
posure to morphine and attribute this to a compen- 
satory upregulation in receptors in response to the 
opiate-induced suppression in central noradrenergic 
transmission {8,41]. Nonetheless, the present data do 
not rule out the possibility that an increase in effi- 
ciency of receptor interaction with G~, which mediates 
/3-adrenergic receptor coupling to adenylate cyclase, 
might also be involved (see for example {15,26]). In 
fact, the finding in earlier studies by Kuriyama et al. 
[15] that coupling between /3-adrenergic receptors and 
adenylate cyclase in rat cerebral cortex may be facili- 
tated during the acute phase of withdrawal suggests 
that alterations in functional responses to/3-adrenergic 
receptor activation might reflect adaptations in postre- 
ceptor events. 
The subsensitivity and decreased responsiveness to 
isoproterenol found in pyramidal neurons in slices from 
morphine-withdrawn animals might result, in part, from 
a down-regulation in postsynaptic /3-adrenergic recep- 
tors that occurs as a consequence of withdrawal-in- 
duced hyperactivity within the L C / N E  system. Several 
groups have reported that the spontaneous activity of 
LC neurons is increased after naloxone-precipitated 
withdrawal in opiate-dependent rats or monkeys 
[2,3,29,37], and this increase in noradrenergic neuronal 
activity in rats has a time course identical to that of 
various withdrawal signs and behaviors [29]. Others 
have demonstrated that the turnover rate of NE is 
increased in rat brain during morphine withdrawal 
[17,32], and in hippocampus this was associated with an 
increased synaptic release of NE, as measured by in 
vivo microdialysis [9]. Since the pyramidal neurons 
constitute a primary target of LC input to the hip- 
pocampus [17,28], postsynaptic /3-adrenergic receptors 
would likely undergo desensitization and possible un- 
coupling from their effector mechanisms due to exces- 
sive activation during the acute phase of withdrawal. 
Such changes might involve covalent modification of 
the receptor by phosphorylation by/3-adrenergic recep- 
tor kinase and subsequent internalization of the recep- 
tor from the membrane {34]. 
Notwithstanding this, results from our earlier bind- 
ing experiments showed hippocampal /3-adrenergic re- 
ceptor density to be reduced only 27% in morphine-de- 
pendent rats studied 32 h after withdrawal [22], which 
is too little to fully account for the changes in the 
isoproterenol concentrat ion-response curve that ac- 
company withdrawal. Thus, it is conceivable that the 
changes in /3-adrenergic receptor function that accom- 
pany withdrawal might involve alterations in post-re- 
ceptor events in addition to a down-regulation in the 
number of membrane receptors. It is noteworthy in this 
regard that neurons in slices from withdrawn rats 
showed a reduced sensitivity without change in maxi- 
mal response to the inhibitory effect of forskolin on the 
slow AHP. The underlying nature of this change 
seemed most likely to be upstream from the Ca 2+- 
activated slow K + conductance, itself (although direct 
measure of the conductance is needed to confirm this), 
since the ability of carbaehol to reduce the slow AHP 
was unaltered in neurons from morphine-withdrawn 
animals. This might involve modifications that affect 
the activity of adenylate cyelase or cAMP-dependent  
protein kinase, but precise information on these issues 
is not available from the present experiments. In future 
studies, we plan to use a comparable electrophysiologi- 
cal approach to assess the activity of these and other 
constituent components of the /3-adrenergic receptor- 
coupled adenylate cyclase cascade in hippocampal neu- 
rons before and at various times after withdrawal of 
morphine-dependent  animals. 
In summary, the present results suggest that the 
increase in pyramidal neuron sensitivity to /3-adren- 
ergic receptor stimulation found in morphine-depend- 
ent animals can largely be attributed to changes in the 
number of membrane receptors.. On the other hand, 
alterations in post receptor events may contribute as 
well to the decrease in functional responsiveness to 
/3-adrenergic agonists that occurs after morphine with- 
drawal. It is possible that the alterations in /3-adren- 
ergic receptor system function demonstrated here may 
not be due to a direct effect of morphine on pyramidal 
neurons, but could reflect compensatory adaptations to 
changes in activity within the LC central noradrenergic 
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system owing to chronic morphine treatment and with- 
drawal. This hypothesis could be tested by determining 
whether intracellular responses of neurons to postsy- 
naptic/3-adrenergic receptor stimulation are altered in 
cultured hippocampal neurons after chronic exposure 
to morphine in vitro in the absence of noradrenergic 
synaptic input. 
Lastly, there is reason to believe that modifications 
occurring within the hippocampus may play an impor- 
tant role in certain behavioral changes and physiologi- 
cal adaptations that are associated with morphine de- 
pendence and tolerance. The hippocampus is known to 
play an important role in learning and memory and 
recent evidence has demonstrated a critical involve- 
ment of these processes in the development of associa- 
tive drug tolerance resulting from an interaction be- 
tween the drug and environment [36]. 
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